| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 7,080 | $30 | $177K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 4,380 | $30 | $144.4K |
| J3262 | Injection, tocilizumab, 1 mg | 24,380 | $10 | $121.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 8,200 | $10 | $90.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 370 | $90 | $32.2K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 300 | $110 | $31.8K |
| J0897 | Injection, denosumab, 1 mg | 1,740 | $20 | $31.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 100 | $70 | $6.5K |
| 96415 | In this add on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report each additional hour of infusion beyond the… | 150 | $20 | $3.4K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 420 | $10 | $3.4K |